LUNG CANCER METASTATIC
Clinical trials for LUNG CANCER METASTATIC explained in plain language.
Never miss a new study
Get alerted when new LUNG CANCER METASTATIC trials appear
Sign up with your email to follow new studies for LUNG CANCER METASTATIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Promising combo tackles tough lung cancer
Disease control CompletedThis study tested a new two-drug combination (bemcentinib plus pembrolizumab) in 99 adults with advanced lung cancer that had already been treated. The goal was to see if the combination could shrink tumors or stop them from growing. Participants received both drugs by mouth or I…
Matched conditions: LUNG CANCER METASTATIC
Phase: PHASE2 • Sponsor: BerGenBio ASA • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Scientists hunt for clues to why immunotherapy fails in most patients
Knowledge-focused CompletedThis study looked at 135 people with advanced lung cancer, lymphoma, or other tumors treated with immunotherapy drugs called checkpoint inhibitors. Researchers collected blood and tumor samples over time to measure immune cells and molecules that might predict whether the treatme…
Matched conditions: LUNG CANCER METASTATIC
Phase: NA • Sponsor: Institut Paoli-Calmettes • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC